Generic Lovenox
July 27, 2010
THE US Food and Drug
Administration has approved the
first generic version of Lovenox
(enoxaparin sodium injection) for
deep vein thrombosis.
The FDA says that before the
approval it received a citizen
petition questioning the approval
process for the medication, but
after careful review the agency
determined that “current scientific
evidence, precedent, and FDA’s
legal authority” established a sound
basis for the approval.
The generic enoxaparin sodium
injection which has gained approval
is manufactured by Sandoz, and is
available in a range of strengths.
MEANWHILE the FDA has also
approved Daiichi Sankyo’s
Tribenzor, which is a new three-inone
combination taken once daily
for the treatment of hypertension.
Tribenzor includes olmesartan
medoximil, amlodipine and
hydrochlorothiazide and is indicated
for patients who are not adequately
controlled on any two of calcium
channel blockers, angiotensin
receptor blockers and diuretics.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jul 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jul 10
